Cargando…

Mycophenolate-Induced Colitis in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Patients

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a prototypic monogenic autoimmune disorder caused by AIRE deficiency-mediated impaired central immune tolerance. Although multiple endocrine and nonendocrine tissues are affected in APECED, the colon is an uncommon target of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmitt, Monica M., Ferré, Elise M. N., Sampaio De Melo, Michelly, Cooper, Megan A., Quezado, Martha M., Heller, Theo, Lionakis, Michail S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins, Inc. 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004485/ https://www.ncbi.nlm.nih.gov/pubmed/35425944 http://dx.doi.org/10.1097/PG9.0000000000000131

Ejemplares similares

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy
por: Ferré, Elise M. N., et al.
Publicado: (2021)

Fatal autoimmune pneumonitis requiring bilobectomy and omental flap repair in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
por: Kubala, Stephanie A., et al.
Publicado: (2021)

Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome
por: Besnard, Marine, et al.
Publicado: (2022)

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy: Insights into Genotype-Phenotype Correlation
por: Capalbo, Donatella, et al.
Publicado: (2012)

Pathogenic and Protective Autoantibodies in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)
por: Kashem, Sakeen W., et al.
Publicado: (2017)

Childhood Polyarthritis As Early Manifestation of Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy Syndrome
por: Gutierrez, Maria J., et al.
Publicado: (2017)

Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy in Two Siblings: Same Mutations but Very Different Phenotypes
por: Carpino, Andrea, et al.
Publicado: (2021)

Long-term Outcome of Kidney Transplantation in 6 Patients With Autoimmune Polyendocrinopathy-candidiasis-ectodermal Dystrophy
por: Laakso, Saila, et al.
Publicado: (2021)

SAT-241 Hyposplenism and Autoimmune Hepatitis: Rare Complications of Autoimmune Polyendocrinopathy Candidiasis and Ectodermal Dystrophy (APECED)
por: Miller, Clare, et al.
Publicado: (2019)

Gastrointestinal manifestations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patient: major effect on treatment and prognosis
por: Ach, Taieb, et al.
Publicado: (2023)

A Rare Case of Autoimmune Polyendocrinopathy-candidiasis-ectodermal Dystrophy Syndrome: Dental Perspective on Diagnosis and Management
por: Tyagi, Rishi, et al.
Publicado: (2023)

Absence of some common organ-specific and non-organ-specific autoimmunity in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy
por: Kluger, Nicolas, et al.
Publicado: (2013)

An Extraordinary Case of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) Syndrome Misdiagnosed as Juvenile Idiopathic Arthritis on Admission
por: Aytac, Gulcin, et al.
Publicado: (2023)

A novel AIRE gene mutation in a patient with autoimmune polyendocrinopathy candidiasis and ectodermal dystrophy revealed by alopecia areata
por: Arousse, Aycha, et al.
Publicado: (2018)

Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome (APECED): A “Rare” Manifestation in a “Rare” Disease
por: Fierabracci, Alessandra
Publicado: (2016)

SAT-LB88 Recurrent Dysphagia Due to an Esophageal Stricture in a Patient With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)
por: Johnson, Timothy, et al.
Publicado: (2020)

SUN-040 Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) Syndrome: Prospective Screening of Asplenism and Pneumonitis in a Cohort of 25 Patients
por: Humbert, Linda, et al.
Publicado: (2019)

A child with autoimmune polyendocrinopathy candidiasis and ectodermal dysplasia treated with immunosuppression: a case report
por: O’Gorman, Clodagh S, et al.
Publicado: (2013)

Molecular and clinical characterization of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) in Iranian non-Jewish patients: report of two novel AIRE gene pathogenic variants
por: Setoodeh, Aria, et al.
Publicado: (2022)

New insights into innate immune control of systemic candidiasis
por: Lionakis, Michail S.
Publicado: (2014)

Candida and Host Determinants of Susceptibility to Invasive Candidiasis
por: Lionakis, Michail S., et al.
Publicado: (2013)

149. Efficacy of Cochleated Amphotericin B (CAMB) in Mouse and Human Mucocutaneous Candidiasis
por: Desai, Jigar V, et al.
Publicado: (2020)

An AIREless Breath: Pneumonitis Caused by Impaired Central Immune Tolerance
por: Ferré, Elise M. N., et al.
Publicado: (2021)

VT-1598 Inhibits the in vitro Growth of Mucosal Candida Isolates and Protects Against Oropharyngeal Candidiasis in IL-17 Deficient Mice
por: Break, Timothy J, et al.
Publicado: (2017)

Mycophenolate Mofetil-Induced Segmental Colitis Mimicking Ischemic Colitis
por: Johal, Kevin, et al.
Publicado: (2014)

Chronic cutaneous candidiasis in children: should we stop there? Report of two cases associated with auto-immune polyendocrinopathy syndrome type I
por: Minka, Basilice Mireille, et al.
Publicado: (2020)

Epidemiology of Hospitalizations Associated with Invasive Candidiasis, United States, 2002–2012
por: Strollo, Sara, et al.
Publicado: (2017)

Mycophenolate-mofetil/prednisolone/rituximab: Treatment-related osteopenia and candidiasis: 7 case reports
Publicado: (2022)

IL-23 signaling prevents ferroptosis-driven renal immunopathology during candidiasis
por: Millet, Nicolas, et al.
Publicado: (2022)

1413. A Phase IIa Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of Encochleated Amphotericin B in Patients with Mucocutaneous (Esophogeal, Oropharyngeal, Vulvovaginal) Candidiasis Who are Refractory or Intolerant to Standard Non-Intravenous Therapies
por: Kibathi, Lilian, et al.
Publicado: (2018)

Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity
Publicado: (1981)

Autoimmune polyendocrinopathy and hypophysitis after Puumala hantavirus infection
por: Tarvainen, Marlene, et al.
Publicado: (2016)

Mycophenolate-Induced Colitis: A Rare Side Effect
por: Bani Fawwaz, Baha Aldeen, et al.
Publicado: (2021)

370. Efficacy of Cochleated Amphotericin B (C-AMB) in Mouse Models of Oropharyngeal and Vulvovaginal Candidiasis
por: Desai, Jigar V, et al.
Publicado: (2018)

Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
por: Meager, Anthony, et al.
Publicado: (2006)

Association pernicious anemia and autoimmune polyendocrinopathy: a retrospective study
por: Zulfiqar, AA, et al.
Publicado: (2017)

Autoimmune thyroiditis - track towards autoimmune polyendocrinopathy type III
por: Hodé, Annelie Kérékou, et al.
Publicado: (2021)

Immune Check Point Inhibitors Triggering Non Autoimmune Polyendocrinopathy
por: Vergne-Santiago, Norma, et al.
Publicado: (2021)

Mycophenolate Mofetil-Induced Colonic Injury Manifesting Endoscopically As Ischemic Colitis
por: Miranda, Clive J, et al.
Publicado: (2023)

Candida albicans ISW2 Regulates Chlamydospore Suspensor Cell Formation and Virulence In Vivo in a Mouse Model of Disseminated Candidiasis
por: Navarathna, Dhammika H. M. L. P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_if02rg8bdeaggvrnua32cn1qbc